✦ LIBER ✦

Are Fractures Secondary to LHRH Agonist Therapy in Prostate Cancer a Significant Problem?

✍ Scribed by Frances Burge; Sadmeet Singh; Owen Cole

Book ID: 118458389
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 119 KB
Volume: 8
Category: Article
ISSN: 1743-9191
DOI: 10.1016/j.ijsu.2010.07.176

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination therapy with flutamide and c

Combination therapy with flutamide and castration (LHRH agonist or orchiectomy) in advanced prostate cancer: A marked improvement in response and survival

✍ F. Labrie; A. Dupont; A. Belanger; M. Giguere; Y. Lacoursiere; J. Emond; G. Monf 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 829 KB

Combination therapy with flutamide and m

Combination therapy with flutamide and medical (LHRH agonist) or surgical castration in advanced prostate cancer: 7-year clinical experience

✍ Labrie, F.; Dupont, A.; Cusan, L.; Gomez, J.; Emond, J.; Monfette, G. 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 708 KB

Sexuality changes in prostate cancer pat

Sexuality changes in prostate cancer patients receiving antihormonal therapy combining the antiandrogen flutamide with medical (LHRH agonist) or surgical castration

✍ L. Rousseau; A. Dupont; F. Labrie; M. Couture 📂 Article 📅 1988 🏛 Springer US 🌐 English ⚖ 620 KB

“LuproCare”: A patient support programme

“LuproCare”: A patient support programme to improve quality of life in patients with prostate cancer treated with LHRH agonists

✍ Steven Joniau; Lieven Goeman; Régine Demaré; Hein Van Poppel 📂 Article 📅 2010 🏛 Dougmar Publishing Group, Inc. 🌐 English ⚖ 285 KB

PD27-11 A PHASE II, RANDOMIZED, DOUBLE-B

PD27-11 A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF METHYLPHENIDATE FOR REDUCTION OF FATIGUE IN PROSTATE CANCER PATIENTS RECEIVING LHRH-AGONIST THERAPY

✍ Richard, Patrick O.; Fleshner, Neil E.; Bhatt, Jaimin R.; Hersey, Karen M.; Chah 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 43 KB

RANK Ligand-targeted Therapy: A Novel Ap

RANK Ligand-targeted Therapy: A Novel Approach to Prevent Bone Loss and Fractures in Men with Prostate Cancer

✍ Matthew R. Smith 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 288 KB